Clinical and Experimental Dermatology and Therapies最新文献

筛选
英文 中文
Impact of a Dispenser in Acne Therapy - “PUMP It” Study with 1,388 Patients 在痤疮治疗的分配器的影响-“泵”研究与1388名患者
Clinical and Experimental Dermatology and Therapies Pub Date : 2018-10-01 DOI: 10.29011/2575-8268/100055
U. Gieler, E. Peters, V. Streit, I. Pulido, D. Porombka, A. Jäckel
{"title":"Impact of a Dispenser in Acne Therapy - “PUMP It” Study with 1,388 Patients","authors":"U. Gieler, E. Peters, V. Streit, I. Pulido, D. Porombka, A. Jäckel","doi":"10.29011/2575-8268/100055","DOIUrl":"https://doi.org/10.29011/2575-8268/100055","url":null,"abstract":"Because daily dosage is difficult to achieve in topical acne therapy, a dispenser was developed to ensure the delivery of a pre-measured amount (0.5 mL) of adapalene 0.1% / benzoyl peroxide 2.5% (adapalene-BPO). This non-interventional study assessed application and convenience of a pump dispenser, treatment adherence, efficacy and safety under daily practice conditions. The included patients (≥ 9 years) with moderate to severe acne received adapalene-BPO in the pump. Assessments were carried out at baseline and after 3 to 12 weeks of treatment. Overall, 1,388 patients were enrolled, and facial acne severity improved in 96.9% of patients. Application was described as easy and time-saving and89.6% of patients used the acne gel regularly. Dysmorphic concerns were reported in 5.6% of acne patients. Adapalene-BPO dispensed from the pump is easy to apply, simplifies acne treatment and leads to good treatment adherence in patients with moderate to severe inflammatory acne.","PeriodicalId":320981,"journal":{"name":"Clinical and Experimental Dermatology and Therapies","volume":"19 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2018-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"134274876","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Involvement of PDGF-BB in the Perivascular Localization of Mesenchymal Stem Cells in Human Skin PDGF-BB参与人皮肤间充质干细胞血管周围定位
Clinical and Experimental Dermatology and Therapies Pub Date : 2018-07-01 DOI: 10.29011/2575-8268/100052
T. Soma
{"title":"Involvement of PDGF-BB in the Perivascular Localization of Mesenchymal Stem Cells in Human Skin","authors":"T. Soma","doi":"10.29011/2575-8268/100052","DOIUrl":"https://doi.org/10.29011/2575-8268/100052","url":null,"abstract":"Somatic stem cells play crucial roles in homeostasis and regeneration of adult tissues. In contrast to the epidermis, several studies have analyzed the exact nature and localization of stem cells in the human dermis. We aimed to elucidate the effect of Platelet-derived Growth Factor (PDGF)-BB on the perivascular existence of Mesenchymal Stem Cells (MSCs), and to analyze the effect of MSCs on dermal homeostasis. We applied a 3D laser scanning confocal microscope to visualize the sites of PDGFBB deposition. Additionally, we analyzed the interactions between MSCs and the microvasculature in the dermis using several in vitro experimental systems including 3D skin equivalents. PDGF-BB accumulation was apparent in the periendothelial portion of the microvasculature in the dermis. MSC migration and colony formation was stimulated by PDGF-BB. Moreover, a significant increase in PDGFB gene expression was observed upon addition of MSC culture supernatant, whereas there was a drastic decrease in Intercellular Adhesion Molecule 1 (ICAM-1) expression. In addition, the production of the dermal components was enhanced in 3D skin equivalents harboring a tubular-like network induced by MSCs. These results indicate that PDGF-BB functions as a key molecule for the existence of MSCs, resulting in an appropriate interaction with the dermal microvasculature.","PeriodicalId":320981,"journal":{"name":"Clinical and Experimental Dermatology and Therapies","volume":"1 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2018-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"128518431","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Increased Plasma Levels of Programmed Death Ligand 1 in Patients with Primary Sjögren's Syndrome 原发性Sjögren综合征患者程序性死亡配体1血浆水平升高
Clinical and Experimental Dermatology and Therapies Pub Date : 2018-07-01 DOI: 10.29011/2575-8268/100050
Cuiping Liu
{"title":"Increased Plasma Levels of Programmed Death Ligand 1 in Patients with Primary Sjögren's Syndrome","authors":"Cuiping Liu","doi":"10.29011/2575-8268/100050","DOIUrl":"https://doi.org/10.29011/2575-8268/100050","url":null,"abstract":"To determine the plasma levels of soluble forms of Programmed Death Ligand 1(sPD-L1) in patients with Primary Sjögren’s syndrome (pSS), and determine whether altered circulating sPD-L1 levels correlate with cytokines or clinical manifestations. Plasma levels of sPD-L1 in 64 patients with pSS and 61 healthy controls were examined by enzyme-linked immunosorbent assay (ELISA). Cytokines in plasma were detected using human Th1/Th2/Th17 cytometric bead array (CBA) kit. Data were evaluated for correlations between plasma sPD-L1 levels and clinical features. Levels of sPD-L1 differed significantly between patients and healthy controls (0.7025±0.04645 versus 0.3642±0.01713, P < 0.0001). Plasma sPD-L1 were positively correlated with IgM (r = 0.3898, P = 0.0129), ESR (r = 0.3801, P = 0.0084), RF (r = 0.4163, P = 0.0198), ALT(r= 0.3028, P = 0.0457), AST (r=0.4455,P=0.0028), and the ESSDAI score (r= 0.3866, P = 0.0066). In addition, PD-L1 levels in plasma were correlated significantly with IFN-γ (r = 0.3685, P = 0.0092) and IL-17 (r =0.3436, P = 0.0127). Plasma sPD-L1 levels may increase in patients with pSS and correlate with the severity of disease. PD-1/PD-L1 interaction may contribute to the development of pSS.","PeriodicalId":320981,"journal":{"name":"Clinical and Experimental Dermatology and Therapies","volume":"2 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2018-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"129944201","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书